135525-71-2

135525-71-2 structure

Name: L 696229
Chemical Name: 3-[2-(1,3-benzoxazol-2-yl)ethyl]-5-ethyl-6-methyl-1H-pyridin-2-one
CAS Number: 135525-71-2
Molecular Formula: C₁₇H₁₈N₂O₂
Molecular Weight: 282.33700
Catalog: Signaling Pathways Anti-infection HIV
Create Date: 2016-05-19 22:09:51
Modify Date: 2024-01-05 22:11:27
L 696229 is a specific inhibitor ofhuman immunodeficiency virus type 1 (HIV-1)reverse transcriptase (RT) activity that possesses antiviral activity[1].

Name	3-[2-(1,3-benzoxazol-2-yl)ethyl]-5-ethyl-6-methyl-1H-pyridin-2-one
Synonyms	3-[2-(Benzoxazol-2-yl)ethyl]-5-ethyl-6-methyl-pyridin-2(1H)-one 2-pyridinol,3-[2-(2-benzoxazolyl)ethyl]-5-ethyl-6-methyl 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methyl-2-(1H)-pyridinone

Description	L 696229 is a specific inhibitor ofhuman immunodeficiency virus type 1 (HIV-1)reverse transcriptase (RT) activity that possesses antiviral activity[1].
Related Catalog	Signaling Pathways >> Anti-infection >> HIV Research Areas >> Infection
References	[1]. Goldman ME, et al. L-696,229 specifically inhibits human immunodeficiency virus type 1 reverse transcriptase and possesses antiviral activity in vitro. Antimicrob Agents Chemother. 1992;36(5):1019-1023.

Density	1.149g/cm3
Boiling Point	496.5ºC at 760mmHg
Molecular Formula	C₁₇H₁₈N₂O₂
Molecular Weight	282.33700
Flash Point	254.1ºC
Exact Mass	282.13700
PSA	59.15000
LogP	3.58440
Vapour Pressure	5.37E-10mmHg at 25°C
Index of Refraction	1.58

139548-67-7

~93%

135525-71-2

Literature: Saari; Hoffman; Wai; Fisher; Rooney; Smith; Thomas; Goldman; O'Brien; Nunberg; Quintero; Schleif; Emini; Stern; Anderson Journal of Medicinal Chemistry, 1991 , vol. 34, # 9 p. 2922 - 2925

136562-05-5

135525-71-2

Literature: Saari; Hoffman; Wai; Fisher; Rooney; Smith; Thomas; Goldman; O'Brien; Nunberg; Quintero; Schleif; Emini; Stern; Anderson Journal of Medicinal Chemistry, 1991 , vol. 34, # 9 p. 2922 - 2925

139393-87-6

135525-71-2

Literature: Saari; Hoffman; Wai; Fisher; Rooney; Smith; Thomas; Goldman; O'Brien; Nunberg; Quintero; Schleif; Emini; Stern; Anderson Journal of Medicinal Chemistry, 1991 , vol. 34, # 9 p. 2922 - 2925

95-21-6

135525-71-2

Literature: Hoffman; Smith; Rooney; Fisher; Wai; Thomas; Bamberger; Barnes; Williams; Jones; Olson; O'Brien; Goldman; Nunberg; Quintero; Schleif; Emini; Anderson Journal of Medicinal Chemistry, 1993 , vol. 36, # 8 p. 953 - 966

139393-89-8

135525-71-2

Literature: Saari; Hoffman; Wai; Fisher; Rooney; Smith; Thomas; Goldman; O'Brien; Nunberg; Quintero; Schleif; Emini; Stern; Anderson Journal of Medicinal Chemistry, 1991 , vol. 34, # 9 p. 2922 - 2925

107-87-9

135525-71-2

Literature: Saari; Hoffman; Wai; Fisher; Rooney; Smith; Thomas; Goldman; O'Brien; Nunberg; Quintero; Schleif; Emini; Stern; Anderson Journal of Medicinal Chemistry, 1991 , vol. 34, # 9 p. 2922 - 2925

Precursor 5
136562-05-5 139393-87-6 95-21-6 139393-89-8
107-87-9
DownStream 0

1545486-94-9	1158522-08-7
940364-43-2	134104-43-1
1804433-69-9	131615-57-1
6906-52-1	930439-75-1
1018584-77-4	1375289-11-4